IMMG Projected Dividend Yield
Immage Biotherapeutics Corp ( OTCBB : IMMG )Immage Biotherapeutics is a development stage biotechnology company engaged in developing immunotherapy biologics to treat various cancers. Co. focuses on the development of a universal vaccine that could be targeted to several tumors that expresses the cancer tumor antigen MAGE-A. The MAGE-A family of antigen has several different isomers that MAGE-A1 to MAGE-A12. Because MAGE-A is a cancer testis antigen it is found beyond the blood-testis antigen. 20 YEAR PERFORMANCE RESULTS |
IMMG Dividend History Detail IMMG Dividend News IMMG Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |